Kelly R. Barnett

Kelly R. Barnett

Auto-generated profile, based on publicly available information

Kelly R. Barnett

Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
JGJozsef Gal
Jozsef Gal
LKLisha Kuang
Lisha Kuang
KBKelly R. Barnett
Kelly R. Barnett
BZBrian Z. Zhu
Brian Z. Zhu
SSSusannah C. Shissler
Susannah C. Shissler
HZHaining Zhu
Haining Zhu
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Mutations in Cu/Zn superoxide dismutase (SOD1) are responsible for approximately 20 % of the familial ALS cases. ALS-causing SOD1 mutants display a gain-of-toxicity phenotype, but the nature of this toxicity is still not fully understood. The Ras GTPase-activating protein-binding protein G3BP1 plays a critical role in stress granule dynamics. Alterations in the dynamics of stress granules have been reported in several other forms of ALS unrelated to SOD1. To our surprise, the mutant G93A SOD1 transgenic mice exhibited pathological cytoplasmic inclusions that co-localized with G3BP1-positive granules in spinal cord motor neurons. The co-localization was also observed in fibroblast cells derived from familial ALS patient carrying SOD1 mutation L144F. Mutant SOD1, unlike wild-type SOD1, interacted with G3BP1 in an RNA-independent manner. Moreover, the interaction is specific for G3BP1 since mutant SOD1 showed little interaction with four other RNA-binding proteins implicated in ALS. The RNA-binding RRM domain of G3BP1 and two particular phenylalanine residues (F380 and F382) are critical for this interaction. Mutant SOD1 delayed the formation of G3BP1- and TIA1-positive stress granules in response to hyperosmolar shock and arsenite treatment in N2A cells. In summary, the aberrant mutant SOD1–G3BP1 interaction affects stress granule dynamics, suggesting a potential link between pathogenic SOD1 mutations and RNA metabolism alterations in ALS.

1 May 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JGJozsef Gal
Jozsef Gal
JCJing Chen
Jing Chen
KBKelly R. Barnett
Kelly R. Barnett
LYLiuqing Yang
Liuqing Yang
EBErin Brumley
Erin Brumley
HZHaining Zhu
Haining Zhu
Histone deacetylase 6 (HDAC6) is a tubulin deacetylase that regulates protein aggregation and turnover. Mutations in Cu/Zn superoxide dismutase (SOD1) linked to familial amyotrophic lateral sclerosis (ALS) make the mutant protein prone to aggregation. However, the role of HDAC6 in mutant SOD1 aggregation and the ALS etiology is unclear. Here we report that HDAC6 knockdown increased mutant SOD1 aggregation in cultured cells. Different from its known role in mediating the degradation of poly-ubiquitinated proteins, HDAC6 selectively interacted with mutant SOD1 via two motifs similar to the SOD1 mutant interaction region (SMIR) that we identified previously in p62/sequestosome 1. Expression of the aggregation-prone mutant SOD1 increased α-tubulin acetylation, and the acetylation-mimicking K40Q α-tubulin mutant promoted mutant SOD1 aggregation. Our results suggest that ALS-linked mutant SOD1 can modulate HDAC6 activity and increase tubulin acetylation, which, in turn, facilitates the microtubule- and retrograde transport-dependent mutant SOD1 aggregation. HDAC6 impairment might be a common feature in various subtypes of ALS.

24 July 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KSKristy R. Stengel
Kristy R. Stengel
KBKelly R. Barnett
Kelly R. Barnett
JWJing Wang
Jing Wang
QLQi Liu
Qi Liu
EHEmily Hodges
Emily Hodges
SBSrividya Bhaskara
Srividya Bhaskara
Significance: Successful rearrangement of the immunoglobulin locus is critical for B-cell development in the bone marrow and the function of our immune system. Here, we used a conditional gene deletion mouse strain to show that Hdac3 is required for the regulation of chromatin structure and for the productive recombination of the IgH locus, which creates immune diversity and allows B-cell maturation. Although the importance of Hdac3 deacetylase activity was recently drawn into question, we used bone marrow transplantation assays to demonstrate the requirement of Hdac3 deacetylase activity for the production of a fully recombined B-cell receptor, progenitor B-cell survival, and successful differentiation to mature B cells.

26 August 2022 in Leukemia
Verified
Journal Article
Open access
PDF file
BBBrennan P. Bergeron
Brennan P. Bergeron
JDJonathan D. Diedrich
Jonathan D. Diedrich
YZYang Zhang
Yang Zhang
KBKelly R. Barnett
Kelly R. Barnett
QDQian Dong
Qian Dong
DSDaniel Savic
Daniel Savic
Glucocorticoids (GCs) are a mainstay of contemporary, multidrug chemotherapy in the treatment of childhood acute lymphoblastic leukemia (ALL), and resistance to GCs remains a major clinical concern. Resistance to GCs is predictive of ALL relapse and poor clinical outcome, and therefore represents a major hurdle limiting further improvements in survival rates. While advances have been made in identifying genes implicated in GC resistance, there remains an insufficient understanding of the impact of cis-regulatory disruptions in resistance. To address this, we mapped the gene regulatory response to GCs in two ALL cell lines using functional genomics and high-throughput reporter assays and identified thousands of GC-responsive changes to chromatin state, including the formation of over 250 GC-responsive super-enhancers and a depletion of AP-1 bound cis-regulatory elements implicated in cell proliferation and anti-apoptotic processes. By integrating our GC response maps with genetic and epigenetic datasets in primary ALL cells from patients, we further uncovered cis-regulatory disruptions at GC-responsive genes that impact GC resistance in childhood ALL. Overall, these data indicate that GCs initiate pervasive effects on the leukemia epigenome, and that alterations to the GC gene regulatory network contribute to GC resistance.

15 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKelly R. Barnett
Kelly R. Barnett
RMRobert Jackson Mobley
Robert Jackson Mobley
JDJonathan D. Diedrich
Jonathan D. Diedrich
BBBrennan P. Bergeron
Brennan P. Bergeron
KBKashi Raj Bhattarai
Kashi Raj Bhattarai
DSDaniel Savic
Daniel Savic
SUMMARY: B-cell lineage acute lymphoblastic leukemia (B-ALL) is comprised of diverse molecular subtypes and while transcriptional and DNA methylation profiling of B-ALL subtypes has been extensively examined, the accompanying chromatin landscape is not well characterized for many subtypes. We therefore mapped chromatin accessibility using ATAC-seq for 10 B-ALL molecular subtypes in primary ALL cells from 154 patients. Comparisons with B-cell progenitors identified candidate B-ALL cell-of-origin and AP-1-associated cis -regulatory rewiring in B-ALL. Cis -regulatory rewiring promoted B-ALL-specific gene regulatory networks impacting oncogenic signaling pathways that perturb normal B-cell development. We also identified that over 20% of B-ALL accessible chromatin sites exhibit strong subtype enrichment, with transcription factor (TF) footprint profiling identifying candidate TFs that maintain subtype-specific chromatin architectures. Over 9000 inherited genetic variants were further uncovered that contribute to variability in chromatin accessibility among individual patient samples. Overall, our data suggest that distinct chromatin architectures are driven by diverse TFs and inherited genetic variants which promote unique gene regulatory networks that contribute to transcriptional differences among B-ALL subtypes. HIGHLIGHTS: Pro-B progenitor cells as the most common cell-of-origin for B-ALL AP-1 TF-associated cis -regulatory rewiring in B-ALL Subtype-specific accessible chromatin signatures representing 20% of all B-ALL sites Role for distinct TFs in promoting subtype-specific chromatin architectures Thousands of inherited genetic variants identified impacting chromatin state

1 May 2026 in Science Advances
Verified
Journal Article
Open access
KBKHADIJA BANU
KHADIJA BANU
MKMohammad Aslam Khan
Mohammad Aslam Khan
SLSihan Li
Sihan Li
MRMorgan Reynolds-Gagliano
Morgan Reynolds-Gagliano
XWXiaofei Wang
Xiaofei Wang
SBSamuel W. Brady
Samuel W. Brady
Cancer therapeutics frequently fail in clinical trials because of poor therapeutic index (efficacy-to-toxicity ratio). We systematically identified targets likely to have a good therapeutic index, revealing insulin receptor substrate 4 (IRS4) as a dependency in IRS4 -expressing cancers. Pan-cancer analysis of pediatric-enriched cancers revealed IRS4 expression consistent with dependency in 68% of choroid plexus, 37% of malignant rhabdoid, 31% of NUT midline, and 5% of osteosarcomas, while in adult cancers, it was expressed in 8% of uterine leiomyosarcomas and 1 to 2% of lung squamous, stomach, and breast carcinomas. IRS4 expression in adult tumors was associated with enhancer hijacking rearrangements, including recurrent GATA3-IRS4 and ANKRD30A-IRS4 in breast cancer, while rhabdoid and NUT midline cancers expressed IRS4 epigenetically. IRS4 fueled cancer dependency through PI3K-Akt activation, and domain analysis revealed the PH and PTB domains, which have a predicted drug pocket, to be dispensable, suggesting degradation-based modalities. These data reveal IRS4 as a target in IRS4-expressing cancers and suggest inhibitory approaches.